Mumps virus strain b level jeryl lynn live antigen

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Mumps virus strain b level jeryl lynn live antigen
Accession Number
DB10316
Type
Biotech
Groups
Approved, Investigational
Biologic Classification
Vaccines
Attenuated
Description

Mumps virus strain b level jeryl lynn live antigen is a live attenuated virus vaccine for subcutenous injection. It is an active immunization against mumps, which is a common childhood disease.

Synonyms
  • Mumps Virus Vaccine Live, Jeryl Lynn Strain
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
M-M-R IIMumps virus strain b level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus strain enders' attenuated edmonston live antigen (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousPhysicians Total Care, Inc.1996-08-072012-06-30Us
M-M-R IIMumps virus strain b level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus strain enders' attenuated edmonston live antigen (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousA-S Medication Solutions1971-04-21Not applicableUs
M-M-R IIMumps virus strain b level jeryl lynn live antigen (12500 [TCID_50]/0.5mL) + Measles virus strain enders' attenuated edmonston live antigen (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousMerck Sharp & Dohme Corp.1971-04-21Not applicableUs
M-M-R IIMumps virus strain b level jeryl lynn live antigen (12500 TCID50/0.5mL) + Measles virus strain enders' attenuated edmonston live antigen (1000 TCID50/0.5mL) + Rubella virus vaccine (1000 TCID50/0.5mL)Powder, for solutionSubcutaneousMerck Ltd.1979-12-31Not applicableCanada
PriorixMumps virus strain b level jeryl lynn live antigen (103.7 CCID50/0.5mL) + Measles virus strain enders' attenuated edmonston live antigen (103.0 CCID50/0.5mL) + Rubella virus vaccine (103.0 CCID50/0.5mL)Kit; Powder, for solutionIntramuscular; SubcutaneousGlaxosmithkline Inc1998-12-04Not applicableCanada
ProQuadMumps virus strain b level jeryl lynn live antigen (20000 [TCID_50]/0.5mL) + Measles virus strain enders' attenuated edmonston live antigen (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) + Varicella Zoster Vaccine (Live/Attenuated) (9772 [PFU]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousMerck Sharp & Dohme Limited2005-09-062018-08-31Us
ProQuadMumps virus strain b level jeryl lynn live antigen (4.3 log10 tcid50/0.5mL) + Measles virus strain enders' attenuated edmonston live antigen (3 log10 tcid50/0.5mL) + Rubella virus vaccine (3 log10 tcid50/0.5mL) + Varicella Zoster Vaccine (Live/Attenuated) (3.99 log10 tcid50/0.5mL)Powder, for solutionSubcutaneousMerck Ltd.2014-05-09Not applicableCanada
ProQuadMumps virus strain b level jeryl lynn live antigen (20000 [TCID_50]/0.5mL) + Measles virus strain enders' attenuated edmonston live antigen (1000 [TCID_50]/0.5mL) + Rubella virus vaccine (1000 [TCID_50]/0.5mL) + Varicella Zoster Vaccine (Live/Attenuated) (9772 [PFU]/0.5mL)Injection, powder, lyophilized, for suspensionSubcutaneousMerck Sharp & Dohme Corp.2015-07-01Not applicableUs
Categories
UNII
47QB6MX9KU
CAS number
Not Available

Pharmacology

Indication
Not Available
Associated Conditions
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Substance
347910495

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedPreventionBacterial Infections / Virus Diseases1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
Injection, powder, lyophilized, for suspensionSubcutaneous
Powder, for solutionSubcutaneous
Kit; powder, for solutionIntramuscular; Subcutaneous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on December 01, 2015 13:03 / Updated on July 13, 2019 00:54